Is your organization engaged in the discovery or development of a novel product with the potential to help patients with inflammatory bowel disease (IBD)? If so, we want to hear from you!
The Crohn's & Colitis Foundation seeks to accelerate the development of products that aim to improve the quality of life of patients with inflammatory bowel diseases. Toward that end, the Foundation has launched IBD Ventures, a new program and dedicated funding mechanism to support product-oriented research and development. Companies and academic investigators can apply. Funding up to $500,000 per project per year will be considered. In addition, funded programs will be offered accelerator resources and advising.
Research & development (R&D) projects will be funded to advance the discovery or development of a specific product candidate with potential for positive impact in the IBD field. Funded projects should be approximately 12 months in duration, with specific intermediate and final milestones identified at project onset. Funding up to $500,000 per project per year will be considered, inclusive of all direct and indirect expenses. Indirect expenses may not exceed 10%. Project funding may be extended past the first year if milestones are met. Projects that require lower levels of funding are also welcome. Project cost-sharing, through which Foundation funds would be complemented using additional sources of funding to achieve project goals, is encouraged. The Foundation will not request intellectual property (IP) ownership in funded technologies. In the event that the funded technology becomes commercially successful, the Foundation would receive a financial return (see Appendix C).
In addition to direct funding, the Crohn’s & Colitis Foundation will provide accelerator resources to support for funded programs. Such support will be tailored to the specific program and may include scientific review; strategic advising; patient and clinician insights; assistance in identifying research resources; facilitation of strategic partnerships (including identification of and referral to specific potential partners); assistance with clinical trial recruitment; presentation opportunities; and consideration for future Foundation funding opportunities. Accelerator support will be provided by Foundation staff, advisors and partners.
Upcoming Letter of Intent deadlines: February 20, 2023; September 2, 2022